Plant ID: NPO1918
Plant Latin Name: Magnolia kobus
Taxonomy Genus: Magnolia
Taxonomy Family: Magnoliaceae
NCBI TaxonomyDB:
54732
Plant-of-the-World-Online:
n.a.
China
TSHR; | |
MAPK1; | |
ALOX15; ALDH1A1; | |
MMP3; | |
TP53; | |
MAPT; LMNA; | |
SMN1;SMN2; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Metallo protease | MMP3 | Matrix metalloproteinase 3 | P08254 | CHEMBL283 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0009987; cellular process | GO:0031334; positive regulation of protein complex assembly | 2.158E-06 | 4.698E-02 | ALOX15, MAPT, MMP3, TP53 |
BP | GO:0050896; response to stimulus | GO:0034614; cellular response to reactive oxygen species | 1.393E-05 | 8.530E-02 | MAPK1, MMP3, TP53 |
BP | GO:0009987; cellular process | GO:0033554; cellular response to stress | 1.667E-05 | 8.530E-02 | ALOX15, LMNA, MAPK1, MAPT, MMP3, TP53 |
BP | GO:0050896; response to stimulus | GO:0010035; response to inorganic substance | 3.700E-05 | 8.579E-02 | ALOX15, MAPK1, MMP3, TP53 |
MF | GO:0005488; binding | GO:0051721; protein phosphatase 2A binding | 7.249E-05 | 9.285E-02 | MAPT, TP53 |
CC | GO:0044464; cell part | GO:0032838; plasma membrane bounded cell projection cytoplasm | 4.200E-04 | 2.029E-01 | MAPK1, MAPT |
MF | GO:0060089; molecular transducer activity | GO:0004996; thyroid-stimulating hormone receptor activity | 9.317E-04 | 2.568E-01 | TSHR |
MF | GO:0003824; catalytic activity | GO:0047977; hepoxilin-epoxide hydrolase activity | 9.317E-04 | 2.568E-01 | ALOX15 |
MF | GO:0003824; catalytic activity | GO:0050473; arachidonate 15-lipoxygenase activity | 1.397E-03 | 3.105E-01 | ALOX15 |
MF | GO:0003824; catalytic activity | GO:0004052; arachidonate 12-lipoxygenase activity | 1.397E-03 | 3.105E-01 | ALOX15 |
CC | GO:0043226; organelle | GO:0016604; nuclear body | 3.575E-03 | 4.972E-01 | LMNA, MAPT, TP53 |
CC | GO:0044464; cell part | GO:0030424; axon | 5.969E-03 | 5.962E-01 | MAPK1, MAPT |
CC | GO:0044464; cell part | GO:0030673; axolemma | 7.432E-03 | 6.321E-01 | MAPT |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 2.734E-05 | 3.035E-03 | LMNA, MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05216 | Thyroid cancer | 7.262E-05 | 4.031E-03 | MAPK1, TP53 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04010 | MAPK signaling pathway | 1.626E-04 | 4.304E-03 | MAPK1, MAPT, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05219 | Bladder cancer | 1.463E-04 | 4.304E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05223 | Non-small cell lung cancer | 2.737E-04 | 4.304E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05213 | Endometrial cancer | 2.359E-04 | 4.304E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05214 | Glioma | 3.690E-04 | 4.304E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05210 | Colorectal cancer | 3.357E-04 | 4.304E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05212 | Pancreatic cancer | 3.804E-04 | 4.304E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05218 | Melanoma | 4.402E-04 | 4.304E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 3.920E-04 | 4.304E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05220 | Chronic myeloid leukemia | 4.653E-04 | 4.304E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05215 | Prostate cancer | 6.907E-04 | 5.898E-03 | MAPK1, TP53 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04668 | TNF signaling pathway | 1.052E-03 | 7.710E-03 | MMP3, MAPK1 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 1.091E-03 | 7.710E-03 | ALOX15, MAPK1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04919 | Thyroid hormone signaling pathway | 1.209E-03 | 7.710E-03 | MAPK1, TP53 |
09150 Organismal Systems | 09156 Nervous system | hsa04722 | Neurotrophin signaling pathway | 1.250E-03 | 7.710E-03 | MAPK1, TP53 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04071 | Sphingolipid signaling pathway | 1.250E-03 | 7.710E-03 | MAPK1, TP53 |
09160 Human Diseases | 09167 Infectious diseases | hsa05160 | Hepatitis C | 1.533E-03 | 8.953E-03 | MAPK1, TP53 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Cancer | C00-C96 | MAPK1; TP53; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | MMP3; |
I00-I99: Diseases of the circulatory system | Myocardial infarction | I21, I22 | MMP3; |
H60-H95: Diseases of the ear and mastoid process | Hearing disorder | H90.5 | TP53; |
C00-D49: Neoplasms | Head and neck cancer | C07-C14, C32-C33 | TP53; |
A00-B99: Certain infectious and parasitic diseases | HCV infection | B17.1, B18.2 | MMP3; |
C00-D49: Neoplasms | Oral cavity cancer | C00-C08 | TP53; |
I00-I99: Diseases of the circulatory system | Ischemic stroke | I61-I63 | MMP3; |
C00-D49: Neoplasms | Hematological malignancies | C81-C86 | TP53; |
C00-D49: Neoplasms | Late-stage solid tumors | C00-C75, C7A, C7B, D10-D36, D3A | TP53; |
I00-I99: Diseases of the circulatory system | Restenosis | I51.89 | MAPK1; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MAPK1; TP53; |
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | TP53; |
C00-D49: Neoplasms | Acute myeloid leukemia | C92.0 | TP53; |
H00-H59: Diseases of the eye and adnexa | Corneal ulcers | H16.0 | MMP3; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Osteoarthritis | M15-M19, M47 | MMP3; |
I00-I99: Diseases of the circulatory system | Renal artery disease | I70.1 | TP53; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Toxicity | T36-T50, T51-T65 | TP53; |